世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031642

腫瘍マーカー:癌の謎を解明(アメリカ、ヨーロッパ、日本)― 腫瘍マーカーおよび国別の企業シェアおよび市場セグメント予測、競合分析、技術的ブレークスルー、新興市場

VPGMarketResearch

Tumor Markers: Unlocking Mystery of Cancer--US, Europe, Japan--Suppliers Shares and Market Segment Forecasts by Tumor Marker and Country, Competitive Analysis, Technological Breakthroughs, Emerging Markets

発刊日 2022/03/22

言語英語

体裁PDF/DataPack

ライセンス/価格

0000031642

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、今後5年間に世界の癌診断市場に出現する主なビジネスチャンスについて調査したものです。また、アメリカ、ヨーロッパ、および日本の動向、現在および新たなアッセイのレビュー、新しい診断技術の潜在的なアプリケーションの分析、国および市場セグメント別の主要な腫瘍マーカーの売上予測、主要企業と潜在的な市場参入企業のプロファイル、企業にとっての特定のビジネスチャンスを明らかにします。

本レポートはセクションごとに用意されており、特定の情報ニーズや予算に応じてカスタマイズすることができます。

論理的根拠

癌診断市場は、研究者が腫瘍診断と治療における主要な技術的ブレークスルーに近づき、新しい特異的抗原を発見し、病気の遺伝的基盤の謎を解くことで、爆発的に拡大する寸前です。今後5年間、世界の癌診断薬市場は、刺激的でダイナミック、かつ急速に拡大する分野となることが期待されています。今後予想される技術の飛躍的進歩により、遺伝的素因の決定、特定の腫瘍の検出、癌治療に対する生物学的反応のモニタリングなど、多くの機会が創出されることでしょう。また、高齢者人口の増加により、悪性腫瘍検査装置に対する需要の高まりと、世界的な市場の急速な拡大がさらに加速されるものと思われます。

調査範囲

  • 調査国
    ➣ フランス
    ➣ ドイツ
    ➣ イタリア
    ➣ 日本
    ➣ スペイン
    ➣ イギリス
    ➣ アメリカ
  • 世界市場の概要
    ➣ 国別の5年間の検査件数と売上予測
    ➣ 国別の市場力学、構造、規模、成長、主要企業のレビューなどを含む、包括的な市場セグメンテーション分析
    ➣ 国別の癌診断検査を実施するラボの推定数
    ➣ アメリカ、ヨーロッパ、および日本における癌の統計、病因および最近の開発
  • ビジネスチャンスと戦略的提言
    ➣ 今後5年間で潜在的に重要な市場アピールを伴う特定の新製品開発の機会
    ➣ 新製品の設計基準
    ➣ 市場浸透のための代替戦略
    ➣ 潜在的な市場参入の障壁とリスク
  • 200を超える既存および新規癌診断検査
    ➣ 生化学マーカー
    ➣ 癌遺伝子
    ➣ 成長因子
    ➣ ホルモン
    ➣ コロニー刺激因子
    ➣ リンホカイン
    ➣ 免疫組織化学染色
    ➣ その他(ACTH、AFP、ベータ2ミクログロブリン、CA 15-3 / 27.29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異的抗原、サイトケラチン、エストロゲン受容体、フェリチン、ガストリン、HCG、インスリン、 インターフェロン、インターロイキン、リンパ球サブタイピング、ニューロン特異的エノラーゼ、核、潜血、腫瘍遺伝子、膵臓癌胎児性抗原、パップスミア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸ホスファターゼ、前立腺特異的抗原、S-100タンパク質、セロトニン、シアル酸、 扁平上皮癌Ag、TDT、チミジンキナーゼ、サイログロブリン、組織ポリペプチド抗原など)
  • 企業シェア、売上、検査件数予測
    ➣ 個々の検査および国別の主要な癌診断製品企業の売上および市場シェア
    ➣ 以下における国および市場セグメント別の主要な腫瘍マーカーの5年間の検査件数と売上予測
      ◇ 病院
      ◇ 商業/民間ラボ
      ◇ 診療所/グループ診療
      ◇ 癌クリニック
      ◇ 外来診療センター
  • 機器のレビュー
    ➣ 動作特性、機能、販売価格などを含む、癌検査に使用される主要な分子診断および免疫診断分析装置の分析
  • 技術評価
    ➣ 最新の分子診断法、バイオチップ/マイクロアレイ、バイオセンサー、モノクローナル抗体、イムノアッセイ、染色体解析、IT、人工知能、フローサイトメトリーなどの技術評価と癌診断検査への応用可能性
    ➣ CT、MRI、NMR、PET、フォトニクス分光法などの競合/補完技術のレビュー
    ➣ 新しい癌診断検査および検出技術を開発している企業、大学、研究センターの広範なリスト
  • 競合戦略
    ➣ 革新的な技術や製品を開発している主要なサプライヤーや新興企業について、その売上、製品ポートフォリオ、マーケティング戦術、協力協定、研究開発中の新製品などの戦略的評価

レポート詳細

目次

Table of Contents

I. Introduction

II. Worldwide Market Overview
 1. Market Overview
 2. Worldwide Market Structure
 3. Worldwide Market Size and Growth

III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
 1. Marketing Approaches
 2. Product Complexity
 3. Customer Preference
 4. Established Suppliers
 5. Emerging Suppliers
 6. Major Types of Distributors
 7. Market Segmentation Factor

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
 1. Breast Cancer
 2. Lung Cancer
 3. Colon and Rectum Cancer
 4. Prostate Cancer
 5. Stomach Cancer
 6. Leukemia
 7. Lymphoma
 8. Oral Cancer
 9. Skin Cancer
 10. Uterine Cancer
 11. Ovarian Cancer
 12. Bladder Cancer
B. Major Current And Emerging Cancer Diagnostic Tests
 1. Introduction
 2. Tumor Marker Classification
 3. ACTH
 4. Alpha-Fetoprotein (AFP)
 5. Beta-2 Microglobulin
 6. CA 15-3/27.29
 7. CA 19-9
 8. CA-125
 9. Calcitonin
 10. Carcinoembrionic Antigen (CEA)
 11. Estrogen and Progesterone Receptors
 12. Ferritin
 13. Gastrin
 14. Human Chorionic Gonadotropin (HCG)
 15. Insulin
 16. NSE
 17. Occult Blood
 18. PAP Smear/HPV
 19. Prostatic Acid Phosphatase (PAP)
 20. Prostate-Specific Antigen (PSA)
 21. Squamous Cell Carcinoma Antigen (SCC)
 22. T and B Lymphocytes
 23. TdT
 24. Thyroglobulin
 25. Tissue Polypeptide Antigen (TPA)
 26. Biochemical Tumor Markers
   - ADA
   - B-Protein
   - PNP
   - 5'-Nucleotidase
 27. Oncogenes
   - Abl/abl-bcr
   - AIB1
   - BCL-2
   - BRCA1
   - CD44
   - C-fos
   - C-myb
   - C-myc
   - CYP-17
   - Erb-B
   - HPC1
   - N-myc
   - P40
   - P51
   - P53
   - PIK3CA
   - PTI-1
   - Ras
   - Reg
   - Sis
   - Src
 28. Polypeptide Growth Factors
   - Basic Fibroblast Growth Factor
   - Beta-TGF
   - Cachectin (TNT)
   - Calmodulin
   - ECFR
   - Nerve Growth Factor (NGF)
   - Epidermal Growth Factor (EGF)
   - Ornithine Decarboxylase
   - Transferrin
   - Transforming Growth Factor-Alpha
 29. Ectopic Hormones
 30. Colony Stimulating Factors
 31. Lymphokines
   - Alpha-Interferon
   - B Cell Growth Factors
   - B Cell Growth Factor (BCGF)
   - Gamma-Interferon
   - Interleukin-1 (IL-1)
   - Macrophage Activating Factor
 32. Immunohistochemical Stains
 33. Emerging Tumor Markers
   - N-Acetylglucosamine
   - Actin
   - Alpha-Actin
   - Antineuronal Antibodies
   - 7B2
   - B72.3
   - Bax
   - BCD-F9
   - BLCA-4
   - Blood Group Antigens A,B,H
   - CA 50
   - CA 72-4/TAG-72
   - CA 195
   - CA-242
   - CA-549
   - CAM 26
   - CAR-3
   - Cathepsin-D
   - Chromogranin A and B
   - Cluster 1 Antigen
   - Cluster-5/5A Antigen
   - CTA
   - CU18
   - DR-70
   - DU-PAN-2
   - Endometrial Bleeding Associated Factor
   - Endostatin
   - Epithelial Membrane Antigen
   - Feulgen Hydrolysis
   - Fibronectin
   - FSH
   - (1->3)-L-fucosyltransferase
   - Gastrin-Releasing Peptide (GRP)
   - GDCFP-15
   - Glucagon
   - Glycoamines
   - H23
   - Her-2
   - Human Carcinoma Antigen
   - HPA
   - HSP27
   - Intermediate Filaments
   - Cytokeratins/CK18/Cyfra 21-1
   - Desmin
   - Gliofibrillary Acid Protein
   - Neurofilaments
   - Vimentin
   - KA 93
   - Kinases
   - KP16D3
   - LAI
   - Leukocyte Common Antigen
   - Lewis Antigens
   - Lysophosphatidic Acid (LPA)
   - Ma 695/Ma 552
   - MABDF3
   - MAG
   - ME1
   - Minactivin
   - MN/CA9
   - MSA
   - Mucin Cancer Antigen (MCA)
   - Multiple Tumor Suppressor 1
   - Myosin
   - NEA-130
   - NMP22
   - OA-519
   - Opiod Peptides
   - P-glycoprotein
   - Pancreatic Oncofetal Antigen (POA)
   - Placental Lactogen
   - PR92
   - Proliferative Index, Ki-67
   - Px
   - RB Inactivation/Deletion
   - Ret
   - SCCL 175
   - Selectin
   - Sialic Acid
   - Sialyl SSEA-1/SLX
   - SN10
   - Somatostatin
   - TA-90
   - TABA
   - Tachykinin
   - TAG 12
   - TPS
   - Troponin
   - Tubulin
   - VCAM
   - VEGF
   - Villen
C. Instrumentation Review And Market Needs
D. Current and Emerging Technologies
 1. Molecular Diagnostics
  a. Technology Overview b. Amplification Methods c. Sequencing
  d. Microarrays/Biochips
 2. Monoclonal and Polyclonal Antibodies
 3. Immunoassays
  a. Technological Principle
  b. Radioimmunoassay (RIA)
  c. Enzyme Immunoassays (EIA)
   - Overview
   - ELISA
   - Immunofiltration
   - Particle-Membrane Capture Immunoassay
   - Enzyme Amplification
  d. Fluorescent Immunoassays e. Luminescence
   - Chemiluminescence
   - Bioluminescence f. Latex Agglutination
  g. Immunoprecipitation h. Affinity Chromatographu
  e. Liposome Flow-Injection Immunoassay
 4. Chromosome Analysis
  a. Chronic Myelogenous Leukemia (CML)
  b. Acute Myeloid Leukemia (AML)
  c. Acute Lymphoblastic Leukemia (ALL)
  d. Malignant Lymphomas Lymphoid Malignancies e. Chronic Lymphocytic Leukemia (CLL)
  f. Solid Cancers
  g. Chromosomal Translocation and Oncogenes
 5. Artificial Intelligence
 6. Flow Cytometry
 7. Two Dimensional Gel Electrophoresis (2-DGE)
 8. Biosensors
 9. Competing/Complementing Technologies a. CT
  b. MRI
  c. NMR
  d. PET
  e. Photonics Spectroscopy
E. Personal Testing

VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

XV. Competitive Profiles
   - Abbott
   - Affymetrix
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - bioMerieux
   - Bio-Rad
   - Cepheid
   - Diamedix
   - DiaSorin
   - Eiken Chemical
   - Elitech Group
   - Enzo Biochem
   - Fujirebio
   - Grifols
   - GSK Biologicals
   - Hologic
   - Leica Biosystems
   - Lonza
   - Ortho-Clinical Diagnostics
   - PerkinElmer
   - Qiagen
   - Roche
   - Scienion
   - Sequenom
   - SeraCare
   - Siemens Healthineers
   - Takara Bio
   - Thermo Fisher
   - Wako

XVI. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

List of Tables
Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, Total Tumor Marker Sales by Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, Total Tumor Marker Sales by Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual Test Volume
Japan, Total Tumor Marker Testing Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Japan, Total Tumor Marker
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: U.S., Total Tumor
Marker Test Volume and Sales Forecast by Market Segment
U.S., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual Test Volume
U.S., Physician Office Laboratories
Performing Tumor Marker Tests by Practice Size
U.S., Total Tumor Marker Test Volume
Forecast by Market Segment
U.S., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices
Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Test
U.S., Total Tumor Marker Sales
Forecast by Market Segment
U.S., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S., Total Tumor Marker Sales by Major Supplier
U.S., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics
Sales by Major Supplier
U.S., CEA Testing Market Diagnostics
Sales by Major Supplier
U.S., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market
Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics
Sales by Major Supplier

この商品のレポートナンバー

0000031642

TOP